Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

426 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapy.
Mangala LS, Wang H, Jiang D, Wu SY, Somasunderam A, Volk DE, Lokesh GLR, Li X, Pradeep S, Yang X, Haemmerle M, Rodriguez-Aguayo C, Nagaraja AS, Rupaimoole R, Bayraktar E, Bayraktar R, Li L, Tanaka T, Hu W, Ivan C, Gharpure KM, McGuire MH, Thiviyanathan V, Zhang X, Maiti SN, Bulayeva N, Choi HJ, Dorniak PL, Cooper LJ, Rosenblatt KP, Lopez-Berestein G, Gorenstein DG, Sood AK. Mangala LS, et al. JCI Insight. 2018 Jun 7;3(11):e122387. doi: 10.1172/jci.insight.122387. eCollection 2018 Jun 7. JCI Insight. 2018. PMID: 29889661 Free PMC article. No abstract available.
Strategies for in vivo siRNA delivery in cancer.
Sanguino A, Lopez-Berestein G, Sood AK. Sanguino A, et al. Mini Rev Med Chem. 2008 Mar;8(3):248-55. doi: 10.2174/138955708783744074. Mini Rev Med Chem. 2008. PMID: 18336345 Review.
Liposomal siRNA for ovarian cancer.
Mangala LS, Han HD, Lopez-Berestein G, Sood AK. Mangala LS, et al. Methods Mol Biol. 2009;555:29-42. doi: 10.1007/978-1-60327-295-7_3. Methods Mol Biol. 2009. PMID: 19495686
Novel strategies for reversing platinum resistance.
Shahzad MM, Lopez-Berestein G, Sood AK. Shahzad MM, et al. Drug Resist Updat. 2009 Dec;12(6):148-52. doi: 10.1016/j.drup.2009.09.001. Epub 2009 Oct 4. Drug Resist Updat. 2009. PMID: 19805003 Free PMC article. Review.
Enhancing chemotherapy response with Bmi-1 silencing in ovarian cancer.
Wang E, Bhattacharyya S, Szabolcs A, Rodriguez-Aguayo C, Jennings NB, Lopez-Berestein G, Mukherjee P, Sood AK, Bhattacharya R. Wang E, et al. PLoS One. 2011 Mar 21;6(3):e17918. doi: 10.1371/journal.pone.0017918. PLoS One. 2011. PMID: 21445297 Free PMC article.
ATP11B mediates platinum resistance in ovarian cancer.
Moreno-Smith M, Halder JB, Meltzer PS, Gonda TA, Mangala LS, Rupaimoole R, Lu C, Nagaraja AS, Gharpure KM, Kang Y, Rodriguez-Aguayo C, Vivas-Mejia PE, Zand B, Schmandt R, Wang H, Langley RR, Jennings NB, Ivan C, Coffin JE, Armaiz GN, Bottsford-Miller J, Kim SB, Halleck MS, Hendrix MJ, Bornman W, Bar-Eli M, Lee JS, Siddik ZH, Lopez-Berestein G, Sood AK. Moreno-Smith M, et al. J Clin Invest. 2013 May;123(5):2119-30. doi: 10.1172/JCI65425. Epub 2013 Apr 15. J Clin Invest. 2013. PMID: 23585472 Free PMC article.
Liposomal siRNA nanocarriers for cancer therapy.
Ozpolat B, Sood AK, Lopez-Berestein G. Ozpolat B, et al. Adv Drug Deliv Rev. 2014 Feb;66:110-6. doi: 10.1016/j.addr.2013.12.008. Epub 2013 Dec 30. Adv Drug Deliv Rev. 2014. PMID: 24384374 Free PMC article. Review.
426 results